BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Krasnova IN, Justinova Z, Cadet JL. Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways. Psychopharmacology (Berl) 2016;233:1945-62. [PMID: 26873080 DOI: 10.1007/s00213-016-4235-8] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Chetsawang J, Nudmamud-thanoi S, Phonchai R, Abubakar Z, Govitrapong P, Chetsawang B. Methamphetamine toxicity-induced calcineurin activation, nuclear translocation of nuclear factor of activated T-cells and elevation of cyclooxygenase 2 levels are averted by calpastatin overexpression in neuroblastoma SH-SY5Y cells. NeuroToxicology 2018;67:287-95. [DOI: 10.1016/j.neuro.2018.06.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
2 Sun Z, Ma Y, Duan S, Xie L, Lv J, Huang J, Lin Z, Guo R, Ma S. cAMP Response Element Binding Protein Expression in the Hippocampus of Rhesus Macaques with Chronic Ephedrine Addiction. Biomed Res Int 2017;2017:1931204. [PMID: 29181387 DOI: 10.1155/2017/1931204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
3 Vrajová M, Šlamberová R, Hoschl C, Ovsepian SV. Methamphetamine and sleep impairments: neurobehavioral correlates and molecular mechanisms. Sleep 2021;44:zsab001. [PMID: 33406259 DOI: 10.1093/sleep/zsab001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Shahveisi K, Abdoli N, Farnia V, Khazaie H, Hosseini M, Ghazvini H, Khodamoradi M. REM sleep deprivation before extinction or reinstatement alters methamphetamine reward memory via D1-like dopamine receptors. Pharmacol Biochem Behav 2022;213:173319. [PMID: 34990706 DOI: 10.1016/j.pbb.2021.173319] [Reference Citation Analysis]
5 Shi S, Chen T, Zhao M. The Crosstalk Between Neurons and Glia in Methamphetamine-Induced Neuroinflammation. Neurochem Res 2022. [PMID: 34982394 DOI: 10.1007/s11064-021-03513-9] [Reference Citation Analysis]
6 Zhu L, Li J, Dong N, Guan F, Liu Y, Ma D, Goh EL, Chen T. mRNA changes in nucleus accumbens related to methamphetamine addiction in mice. Sci Rep 2016;6:36993. [PMID: 27869204 DOI: 10.1038/srep36993] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
7 Cadet JL, Krasnova IN, Walther D, Brannock C, Ladenheim B, McCoy MT, Collector D, Torres OV, Terry N, Jayanthi S. Increased expression of proenkephalin and prodynorphin mRNAs in the nucleus accumbens of compulsive methamphetamine taking rats. Sci Rep 2016;6:37002. [PMID: 27841313 DOI: 10.1038/srep37002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
8 Feizipour S, Sobhani S, Mehrafza S, Gholami M, Motaghinejad M, Motevalian M, Safari S, Davoudizadeh R. Selegiline acts as neuroprotective agent against methamphetamine-prompted mood and cognitive related behavior and neurotoxicity in rats: Involvement of CREB/BDNF and Akt/GSK3 signal pathways. Iran J Basic Med Sci 2020;23:606-15. [PMID: 32742598 DOI: 10.22038/ijbms.2020.38827.9221] [Reference Citation Analysis]
9 Ortiz DM, Custodio RJP, Abiero A, Botanas CJ, Sayson LV, Kim M, Lee HJ, Kim HJ, Jeong Y, Yoon S, Lee YS, Cheong JH. The dopaminergic alterations induced by 4-F-PCP and 4-Keto-PCP may enhance their drug-induced rewarding and reinforcing effects: Implications for abuse. Addict Biol 2021;26:e12981. [PMID: 33135332 DOI: 10.1111/adb.12981] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Thomas Broome S, Louangaphay K, Keay KA, Leggio GM, Musumeci G, Castorina A. Dopamine: an immune transmitter. Neural Regen Res 2020;15:2173-85. [PMID: 32594028 DOI: 10.4103/1673-5374.284976] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
11 Keshavarzi S, Kermanshahi S, Karami L, Motaghinejad M, Motevalian M, Sadr S. Protective role of metformin against methamphetamine induced anxiety, depression, cognition impairment and neurodegeneration in rat: The role of CREB/BDNF and Akt/GSK3 signaling pathways. NeuroToxicology 2019;72:74-84. [DOI: 10.1016/j.neuro.2019.02.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
12 Wei Z, Chen L, Zhang J, Cheng Y. Aberrations in peripheral inflammatory cytokine levels in substance use disorders: a meta‐analysis of 74 studies. Addiction 2020;115:2257-67. [DOI: 10.1111/add.15160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Limanaqi F, Gambardella S, Biagioni F, Busceti CL, Fornai F. Epigenetic Effects Induced by Methamphetamine and Methamphetamine-Dependent Oxidative Stress. Oxid Med Cell Longev 2018;2018:4982453. [PMID: 30140365 DOI: 10.1155/2018/4982453] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
14 Wang B, Chen T, Xue L, Wang J, Jia Y, Li G, Ren H, Wu F, Wu M, Chen Y. Methamphetamine exacerbates neuroinflammatory response to lipopolysaccharide by activating dopamine D1-like receptors. International Immunopharmacology 2019;73:1-9. [DOI: 10.1016/j.intimp.2019.04.053] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
15 González B, Torres OV, Jayanthi S, Gomez N, Sosa MH, Bernardi A, Urbano FJ, García-Rill E, Cadet JL, Bisagno V. The effects of single-dose injections of modafinil and methamphetamine on epigenetic and functional markers in the mouse medial prefrontal cortex: potential role of dopamine receptors. Prog Neuropsychopharmacol Biol Psychiatry 2019;88:222-34. [PMID: 30056065 DOI: 10.1016/j.pnpbp.2018.07.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
16 Popescu A, Marian M, Drăgoi AM, Costea RV. Understanding the genetics and neurobiological pathways behind addiction (Review). Exp Ther Med 2021;21:544. [PMID: 33815617 DOI: 10.3892/etm.2021.9976] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Chand S, Gowen A, Savine M, Moore D, Clark A, Huynh W, Wu N, Odegaard K, Weyrich L, Bevins RA, Fox HS, Pendyala G, Yelamanchili SV. A comprehensive study to delineate the role of an extracellular vesicle-associated microRNA-29a in chronic methamphetamine use disorder. J Extracell Vesicles 2021;10:e12177. [PMID: 34913274 DOI: 10.1002/jev2.12177] [Reference Citation Analysis]
18 Sharma A, Harutyunyan A, Schneider BL, Moszczynska A. Parkin regulates drug-taking behavior in rat model of methamphetamine use disorder. Transl Psychiatry 2021;11:293. [PMID: 34001858 DOI: 10.1038/s41398-021-01387-7] [Reference Citation Analysis]
19 Eskandarian Boroujeni M, Peirouvi T, Shaerzadeh F, Ahmadiani A, Abdollahifar MA, Aliaghaei A. Differential gene expression and stereological analyses of the cerebellum following methamphetamine exposure. Addict Biol 2020;25:e12707. [PMID: 30714656 DOI: 10.1111/adb.12707] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
20 Duan S, Ma Y, Xie L, Zheng L, Huang J, Guo R, Sun Z, Xie Y, Lv J, Lin Z, Ma S. Effects of Chronic Ephedrine Toxicity on Functional Connections, Cell Apoptosis, and CREB-Related Proteins in the Prefrontal Cortex of Rhesus Monkeys. Neurotox Res 2020;37:602-15. [PMID: 31858422 DOI: 10.1007/s12640-019-00146-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
21 Tzeng NS, Liu YP. Amphetamine exposure and dementia - A hypothesis of the long term sequelae of cognitive enhancers based on opponent process theory. Med Hypotheses 2019;132:109327. [PMID: 31421431 DOI: 10.1016/j.mehy.2019.109327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Lappin JM, Darke S. Methamphetamine and heightened risk for early-onset stroke and Parkinson's disease: A review. Exp Neurol 2021;343:113793. [PMID: 34166684 DOI: 10.1016/j.expneurol.2021.113793] [Reference Citation Analysis]
23 Vannan A, Powell GL, Dell'Orco M, Wilson MA, Perrone-Bizzozero NI, Neisewander JL. microRNA regulation related to the protective effects of environmental enrichment against cocaine-seeking behavior. Drug Alcohol Depend 2021;221:108585. [PMID: 33647589 DOI: 10.1016/j.drugalcdep.2021.108585] [Reference Citation Analysis]
24 Abiero A, Botanas CJ, Custodio RJ, Sayson LV, Kim M, Lee HJ, Kim HJ, Lee KW, Jeong Y, Seo J, Ryu IS, Lee YS, Cheong JH. 4-MeO-PCP and 3-MeO-PCMo, new dissociative drugs, produce rewarding and reinforcing effects through activation of mesolimbic dopamine pathway and alteration of accumbal CREB, deltaFosB, and BDNF levels. Psychopharmacology 2020;237:757-72. [DOI: 10.1007/s00213-019-05412-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
25 Limanaqi F, Biagioni F, Busceti CL, Ryskalin L, Fornai F. The effects of proteasome on baseline and methamphetamine-dependent dopamine transmission. Neuroscience & Biobehavioral Reviews 2019;102:308-17. [DOI: 10.1016/j.neubiorev.2019.05.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
26 Gonçalves J, Leitão RA, Higuera-Matas A, Assis MA, Coria SM, Fontes-Ribeiro C, Ambrosio E, Silva AP. Extended-access methamphetamine self-administration elicits neuroinflammatory response along with blood-brain barrier breakdown. Brain Behav Immun 2017;62:306-17. [PMID: 28237710 DOI: 10.1016/j.bbi.2017.02.017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
27 Vicente-Rodríguez M, Fernández-Calle R, Gramage E, Pérez-García C, Ramos MP, Herradón G. Midkine Is a Novel Regulator of Amphetamine-Induced Striatal Gliosis and Cognitive Impairment: Evidence for a Stimulus-Dependent Regulation of Neuroinflammation by Midkine. Mediators Inflamm 2016;2016:9894504. [PMID: 28044069 DOI: 10.1155/2016/9894504] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
28 Juárez-Portilla C, Pitter M, Kim RD, Patel PY, Ledesma RA, LeSauter J, Silver R. Brain Activity during Methamphetamine Anticipation in a Non-Invasive Self-Administration Paradigm in Mice. eNeuro 2018;5:ENEURO. [PMID: 29632871 DOI: 10.1523/ENEURO.0433-17.2018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Szechtman H, Harvey BH, Woody EZ, Hoffman KL. The Psychopharmacology of Obsessive-Compulsive Disorder: A Preclinical Roadmap. Pharmacol Rev 2020;72:80-151. [PMID: 31826934 DOI: 10.1124/pr.119.017772] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
30 Abdullah CS, Aishwarya R, Alam S, Morshed M, Remex NS, Nitu S, Kolluru GK, Traylor J, Miriyala S, Panchatcharam M, Hartman B, King J, Bhuiyan MAN, Chandran S, Woolard MD, Yu X, Goeders NE, Dominic P, Arnold CL, Stokes K, Kevil CG, Orr AW, Bhuiyan MS. Methamphetamine induces cardiomyopathy by Sigmar1 inhibition-dependent impairment of mitochondrial dynamics and function. Commun Biol 2020;3:682. [PMID: 33203971 DOI: 10.1038/s42003-020-01408-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
31 Chao J, Zhang Y, Du L, Zhou R, Wu X, Shen K, Yao H. Molecular mechanisms underlying the involvement of the sigma-1 receptor in methamphetamine-mediated microglial polarization. Sci Rep 2017;7:11540. [PMID: 28912535 DOI: 10.1038/s41598-017-11065-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
32 Torres OV, Jayanthi S, McCoy MT, Cadet JL. Selective Activation of Striatal NGF-TrkA/p75NTR/MAPK Intracellular Signaling in Rats That Show Suppression of Methamphetamine Intake 30 Days following Drug Abstinence. Int J Neuropsychopharmacol 2018;21:281-90. [PMID: 29165617 DOI: 10.1093/ijnp/pyx105] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
33 Pilipenko V, Narbute K, Pupure J, Langrate IK, Muceniece R, Kluša V. Neuroprotective potential of antihyperglycemic drug metformin in streptozocin-induced rat model of sporadic Alzheimer's disease. European Journal of Pharmacology 2020;881:173290. [DOI: 10.1016/j.ejphar.2020.173290] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
34 Gu YJ, Chen L, Cheng L, Zhou MY, Wang Y. Non-coding RNA: insights into the mechanism of methamphetamine neurotoxicity. Mol Cell Biochem 2021;476:3319-28. [PMID: 33895910 DOI: 10.1007/s11010-021-04160-y] [Reference Citation Analysis]
35 Custodio RJP, Sayson LV, Botanas CJ, Abiero A, You KY, Kim M, Lee HJ, Yoo SY, Lee KW, Lee YS, Seo J, Ryu IS, Kim HJ, Cheong JH. 25B‐NBOMe, a novel N ‐2‐methoxybenzyl‐phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: Evidence of abuse potential. Addiction Biology 2020;25. [DOI: 10.1111/adb.12850] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
36 Limanaqi F, Biagioni F, Busceti CL, Ryskalin L, Soldani P, Frati A, Fornai F. Cell Clearing Systems Bridging Neuro-Immunity and Synaptic Plasticity. Int J Mol Sci 2019;20:E2197. [PMID: 31060234 DOI: 10.3390/ijms20092197] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
37 Chen L, Ru Q, Xiong Q, Zhou M, Yue K, Wu Y. The Role of Chinese Herbal Therapy in Methamphetamine Abuse and its Induced Psychiatric Symptoms. Front Pharmacol 2021;12:679905. [PMID: 34040537 DOI: 10.3389/fphar.2021.679905] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Re GF, Jia J, Xu Y, Zhang Z, Xie ZR, Kong D, Lu D, Li Y, Peng QY, Yu J, Kuang YQ, Wang KH. Dynamics and correlations in multiplex immune profiling reveal persistent immune inflammation in male drug users after withdrawal. Int Immunopharmacol 2022;107:108696. [PMID: 35303506 DOI: 10.1016/j.intimp.2022.108696] [Reference Citation Analysis]
39 Cisneros IE, Ghorpade A, Borgmann K. Methamphetamine Activates Trace Amine Associated Receptor 1 to Regulate Astrocyte Excitatory Amino Acid Transporter-2 via Differential CREB Phosphorylation During HIV-Associated Neurocognitive Disorders. Front Neurol 2020;11:593146. [PMID: 33324330 DOI: 10.3389/fneur.2020.593146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Kim B, Yun J, Park B. Methamphetamine-Induced Neuronal Damage: Neurotoxicity and Neuroinflammation. Biomol Ther (Seoul) 2020;28:381-8. [PMID: 32668144 DOI: 10.4062/biomolther.2020.044] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
41 Zhao L, Du L, Zhang Y, Chao J, Duan M, Yao H, Shen C, Zhang Y. Role of PUMA in the methamphetamine-induced migration of microglia. Metab Brain Dis 2019;34:61-9. [DOI: 10.1007/s11011-018-0319-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
42 Ni T, Li Y, Wang R, Hu T, Guan F, Zhu L, Han W, Chen T. The potential involvement of miR-204-3p-axon guidance network in methamphetamine-induced locomotor sensitization of mice. Neurosci Lett 2019;707:134303. [PMID: 31153969 DOI: 10.1016/j.neulet.2019.134303] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
43 Walker CS, Raddant AC, Woolley MJ, Russo AF, Hay DL. CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured. Cephalalgia 2018;38:437-51. [PMID: 28165287 DOI: 10.1177/0333102417691762] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 7.8] [Reference Citation Analysis]
44 Prasad A, Kulkarni R, Shrivastava A, Jiang S, Lawson K, Groopman JE. Methamphetamine functions as a novel CD4+ T-cell activator via the sigma-1 receptor to enhance HIV-1 infection. Sci Rep 2019;9:958. [PMID: 30700725 DOI: 10.1038/s41598-018-35757-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
45 Woodcock EA, Hillmer AT, Mason GF, Cosgrove KP. Imaging Biomarkers of the Neuroimmune System among Substance Use Disorders: A Systematic Review. Mol Neuropsychiatry 2019;5:125-46. [PMID: 31312635 DOI: 10.1159/000499621] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
46 Kordas G, Rudra P, Hendricks A, Saba L, Kechris K. Insight into genetic regulation of miRNA in mouse brain. BMC Genomics 2019;20:849. [PMID: 31722663 DOI: 10.1186/s12864-019-6110-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
47 Taheri P, Keshavarzi S, Ebadi M, Motaghinejad M, Motevalian M. Neuroprotective Effects of Forced Exercise and Bupropion on Chronic Methamphetamine-induced Cognitive Impairment via Modulation of cAMP Response Element-binding Protein/Brain-derived Neurotrophic Factor Signaling Pathway, Oxidative Stress, and Inflammatory Biomarkers in Rats. Adv Biomed Res 2018;7:151. [PMID: 30662880 DOI: 10.4103/abr.abr_11_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
48 Wang YC, Chiu WC, Cheng CN, Lee C, Chih Wei Huang A. Examination of neuroinflammatory cytokine interleukin-1 beta expression in the medial prefrontal cortex, amygdala, and hippocampus for the paradoxical effects of reward and aversion induced by morphine. Neurosci Lett 2021;760:136076. [PMID: 34153368 DOI: 10.1016/j.neulet.2021.136076] [Reference Citation Analysis]
49 Qiao X, Gai H, Su R, Deji C, Cui J, Lai J, Zhu Y. PI3K-AKT-GSK3β-CREB signaling pathway regulates anxiety-like behavior in rats following alcohol withdrawal. J Affect Disord 2018;235:96-104. [PMID: 29655081 DOI: 10.1016/j.jad.2018.04.039] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
50 Wen RT, Liang JH, Zhang HT. Targeting Phosphodiesterases in Pharmacotherapy for Substance Dependence. Adv Neurobiol 2017;17:413-44. [PMID: 28956341 DOI: 10.1007/978-3-319-58811-7_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Liśkiewicz A, Przybyła M, Park M, Liśkiewicz D, Nowacka-Chmielewska M, Małecki A, Barski J, Lewin-Kowalik J, Toborek M. Methamphetamine-associated cognitive decline is attenuated by neutralizing IL-1 signaling. Brain Behav Immun 2019;80:247-54. [PMID: 30885840 DOI: 10.1016/j.bbi.2019.03.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
52 Limanaqi F, Busceti CL, Celli R, Biagioni F, Fornai F. Autophagy as a gateway for the effects of methamphetamine: From neurotransmitter release and synaptic plasticity to psychiatric and neurodegenerative disorders. Prog Neurobiol 2021;204:102112. [PMID: 34171442 DOI: 10.1016/j.pneurobio.2021.102112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Lwin T, Yang JL, Ngampramuan S, Viwatpinyo K, Chancharoen P, Veschsanit N, Pinyomahakul J, Govitrapong P, Mukda S. Melatonin ameliorates methamphetamine-induced cognitive impairments by inhibiting neuroinflammation via suppression of the TLR4/MyD88/NFκB signaling pathway in the mouse hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 2021;111:110109. [PMID: 32941923 DOI: 10.1016/j.pnpbp.2020.110109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
54 Vicente-Rodríguez M, Rojo Gonzalez L, Gramage E, Fernández-Calle R, Chen Y, Pérez-García C, Ferrer-Alcón M, Uribarri M, Bailey A, Herradón G. Pleiotrophin overexpression regulates amphetamine-induced reward and striatal dopaminergic denervation without changing the expression of dopamine D1 and D2 receptors: Implications for neuroinflammation. Eur Neuropsychopharmacol 2016;26:1794-805. [PMID: 27642078 DOI: 10.1016/j.euroneuro.2016.09.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
55 Khodamoradi M, Tirgar F, Ghazvini H, Rafaiee R, Tamijani SMS, Karimi N, Yadegari A, Khachaki AS, Akhtari J. Role of the cannabinoid CB1 receptor in methamphetamine-induced social and recognition memory impairment. Neuroscience Letters 2022;779:136634. [DOI: 10.1016/j.neulet.2022.136634] [Reference Citation Analysis]